We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose Reduction in Thoracic CT

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00188461
First Posted: September 16, 2005
Last Update Posted: April 23, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University Health Network, Toronto
  Purpose
Hypothesis: Does a 50% reduction in radiation in dose significantly affect the diagnostic quality of chest CT

Condition Intervention Phase
Lymphoma Device: CT Thorax Phase 1

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Dose Reduction in Thoracic CT: A Comparison of on Line Automatic Dose Reduction and a 50% Reduction in Dose

Resource links provided by NLM:


Further study details as provided by University Health Network, Toronto:

Primary Outcome Measures:
  • Evaluating the diagnostic quality of thoracic CT exams performed at 50% of standard dose parameters

Estimated Enrollment: 100
Study Start Date: January 2004
Estimated Study Completion Date: August 2005
Detailed Description:
Patients with Lymphoma are recruited and have a follow up CT performed at 50% of the standard exposure parameters. The studies are compared for image quality with a recent (<3 months) thoracic CT performed at standard exposure parameters.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   16 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with Lymphoma

Exclusion Criteria:

  • No recent (<3 months) thoracic CT
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00188461


Locations
Canada, Ontario
Toronto General Hospital
Toronto, Ontario, Canada
Sponsors and Collaborators
University Health Network, Toronto
Investigators
Principal Investigator: Narinder Paul, FRCP C University Health Network, Toronto
  More Information

ClinicalTrials.gov Identifier: NCT00188461     History of Changes
Other Study ID Numbers: 03-0875
First Submitted: September 12, 2005
First Posted: September 16, 2005
Last Update Posted: April 23, 2007
Last Verified: September 2005


To Top